Danaher Co. (NYSE:DHR) Stock Position Raised by Edgestream Partners L.P.

Edgestream Partners L.P. lifted its position in Danaher Co. (NYSE:DHR) by 181.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 30,863 shares of the conglomerate’s stock after buying an additional 19,898 shares during the quarter. Edgestream Partners L.P.’s holdings in Danaher were worth $7,085,000 as of its most recent filing with the SEC.

Other hedge funds have also recently added to or reduced their stakes in the company. Howard Capital Management Group LLC boosted its holdings in Danaher by 4.1% in the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock worth $342,000 after purchasing an additional 48 shares in the last quarter. United Advisor Group LLC acquired a new stake in shares of Danaher in the third quarter worth about $230,000. Marks Group Wealth Management Inc boosted its stake in shares of Danaher by 5.0% during the 3rd quarter. Marks Group Wealth Management Inc now owns 4,660 shares of the conglomerate’s stock worth $1,296,000 after acquiring an additional 223 shares in the last quarter. 1834 Investment Advisors Co. increased its holdings in shares of Danaher by 10.8% during the 3rd quarter. 1834 Investment Advisors Co. now owns 1,707 shares of the conglomerate’s stock valued at $475,000 after acquiring an additional 166 shares during the last quarter. Finally, Radnor Capital Management LLC bought a new position in shares of Danaher in the 3rd quarter valued at approximately $591,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Transactions at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 11.10% of the stock is currently owned by insiders.

Danaher Stock Up 2.0 %

Shares of DHR stock opened at $214.76 on Friday. The stock has a market cap of $153.49 billion, a P/E ratio of 40.67, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The stock has a fifty day moving average price of $222.89 and a 200 day moving average price of $243.43. Danaher Co. has a one year low of $196.80 and a one year high of $281.70.

Danaher (NYSE:DHR) last issued its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter last year, the company posted $2.09 EPS. Analysts predict that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a $0.32 dividend. This is a positive change from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a dividend yield of 0.60%. The ex-dividend date of this dividend is Friday, March 28th. Danaher’s dividend payout ratio is currently 24.24%.

Analysts Set New Price Targets

DHR has been the subject of a number of recent analyst reports. Wells Fargo & Company decreased their target price on Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday, January 30th. Robert W. Baird decreased their price objective on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Jefferies Financial Group lowered their target price on shares of Danaher from $285.00 to $260.00 and set a “buy” rating on the stock in a research note on Wednesday, January 29th. The Goldman Sachs Group set a $250.00 target price on shares of Danaher in a research report on Wednesday, January 15th. Finally, Barclays lowered their price target on Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 30th. Seven equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and a consensus price target of $278.00.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.